-
Valeant Pharma (VRX) Raises 'Stalking Horse' Bid on Dendreon to $400M
-
Notable Mergers and Acquisitions 1/30: (VRX)/(DNDNQ) (BAMM) (DKS)
-
Valeant Pharma (VRX) Forerunner in Dendreon Takeover; Submits $296M 'Stalking Horse' Bid
-
UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Valeant (VRX) Sends Letter to Cephalon (CEPH) Shareholders
-
Notable Analyst Rating Changes 01/07: KLIC, SYNT, GT, VRX Upgraded; AKS, HERO, MSFT, PCS Downgraded
-
Lazard Capital Upgrades Valeant Pharmaceuticals (VRX) to Buy
-
Daily State of the Markets 10/11: Has Goldilocks Returned?
-
Notable Analyst Rating Changes 06/22: VRX, LNCR, MAT, ARBA Upgraded; BVF, BIG, WAG, NOV Downgraded
-
Lazard Upgrades Valeant Pharma (VRX) to Hold

